DCF — GLENDIVE MEDICAL CENTER INC
Enterprise Value: $-59.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-59.4M
Enterprise Value
$-19.4M
PV of Cash Flows
$-40.0M
PV of Terminal Value
$-64.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $54.1M | $-3.4M | -6.0% | $-5.7M | $-5.2M |
| Year 2 | $55.8M | $-2.9M | -5.0% | $-5.3M | $-4.4M |
| Year 3 | $57.4M | $-2.4M | -4.0% | $-4.9M | $-3.7M |
| Year 4 | $59.2M | $-2.2M | -4.0% | $-4.7M | $-3.2M |
| Year 5 | $60.9M | $-2.1M | -4.0% | $-4.7M | $-2.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-59.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$52.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06762419450384093
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5